[go: up one dir, main page]

TR200200014T2 - Nörotik düzensizliklerin tedavisi. - Google Patents

Nörotik düzensizliklerin tedavisi.

Info

Publication number
TR200200014T2
TR200200014T2 TR2002/00014T TR200200014T TR200200014T2 TR 200200014 T2 TR200200014 T2 TR 200200014T2 TR 2002/00014 T TR2002/00014 T TR 2002/00014T TR 200200014 T TR200200014 T TR 200200014T TR 200200014 T2 TR200200014 T2 TR 200200014T2
Authority
TR
Turkey
Prior art keywords
disorder
treatment
angleness
neurotic
neurotic disorders
Prior art date
Application number
TR2002/00014T
Other languages
English (en)
Inventor
Sanchez Connie
Hogg Sandra
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8099796&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200200014(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of TR200200014T2 publication Critical patent/TR200200014T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Eskitalopramin (sitalopramin S-(+)-enantiomeri) ya da bunun farmasötik olarak kabul edilebilir bir tuzunun aralarinda angziyete durumlari, özellikle genellestirilmis angziyete düzensizligi ve sosyal angziyete düzensizligi, travma sonrasi stres düzensizligi, obsesif kompülsif düzensizlik ve panik ataklarin bulundugu nörotik düzensizliklerin tedavisinde kullanisli bir ilacin hazirlanmasi için kullanimi.
TR2002/00014T 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi. TR200200014T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199900991 1999-07-08

Publications (1)

Publication Number Publication Date
TR200200014T2 true TR200200014T2 (tr) 2002-05-21

Family

ID=8099796

Family Applications (4)

Application Number Title Priority Date Filing Date
TR2004/02276T TR200402276T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2002/00014T TR200200014T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi.
TR2004/02277T TR200402277T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2004/02275T TR200402275T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2004/02276T TR200402276T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi

Family Applications After (2)

Application Number Title Priority Date Filing Date
TR2004/02277T TR200402277T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi
TR2004/02275T TR200402275T2 (tr) 1999-07-08 2000-07-07 Nörotik düzensizliklerin tedavisi

Country Status (38)

Country Link
US (6) US7271194B2 (tr)
EP (4) EP1200081B1 (tr)
JP (1) JP4773011B2 (tr)
KR (1) KR100604176B1 (tr)
CN (1) CN1198610C (tr)
AR (1) AR021155A1 (tr)
AT (1) ATE339955T1 (tr)
AU (6) AU782514B2 (tr)
BG (4) BG110467A (tr)
BR (1) BR0011578A (tr)
CA (4) CA2687394A1 (tr)
CL (3) CL2008003939A1 (tr)
CO (1) CO5190674A1 (tr)
CY (1) CY1105806T1 (tr)
CZ (1) CZ200270A3 (tr)
DE (1) DE60030861T2 (tr)
DK (1) DK1200081T3 (tr)
EA (1) EA006555B1 (tr)
ES (1) ES2272298T3 (tr)
HK (1) HK1048069B (tr)
HR (1) HRP20010820A2 (tr)
HU (1) HUP0201791A3 (tr)
IL (5) IL146131A0 (tr)
IS (1) IS6137A (tr)
ME (2) ME00032B (tr)
MX (1) MXPA01011626A (tr)
MY (1) MY143278A (tr)
NO (4) NO329021B1 (tr)
PL (1) PL352030A1 (tr)
PT (1) PT1200081E (tr)
SI (1) SI1200081T1 (tr)
SK (1) SK82002A3 (tr)
TR (4) TR200402276T2 (tr)
TW (1) TWI232101B (tr)
UA (1) UA77645C2 (tr)
WO (1) WO2001003694A1 (tr)
YU (1) YU78701A (tr)
ZA (1) ZA200108856B (tr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB0005477D0 (en) 2000-03-07 2000-04-26 Resolution Chemicals Limited Process for the preparation of citalopram
PT1301502E (pt) * 2000-07-21 2005-09-30 Lundbeck & Co As H Compostos e sua utilizacao como inibidores do transporte de glicina
HUP0400054A3 (en) * 2001-05-01 2007-03-28 Lundbeck & Co As H The use of enantiomeric pure escitalopram
AU2002355624B2 (en) 2001-07-31 2006-02-02 H. Lundbeck A/S Crystalline composition containing escitalopram
US20040067963A1 (en) * 2002-07-08 2004-04-08 University Of Florida Methods to prevent or ameliorate trauma-related psychological disorders
EA013116B1 (ru) * 2002-12-23 2010-02-26 Х. Лундбекк А/С Эсциталопрамгидробромид, его применение и фармкомпозиция
US20050137255A1 (en) * 2002-12-23 2005-06-23 H. Lundbeck A/S Crystalline escitalopram hydrobromide and methods for preparing the same
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
US20090093461A1 (en) * 2003-07-02 2009-04-09 Astrazeneca Ab Methods of Treating Anxiety and Mood Disorders
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
PL1708790T3 (pl) * 2003-12-02 2010-10-29 Pharmaneuroboost N V Zastosowanie pipamperonu oraz antagonisty receptora D2 lub antagonisty receptora serotoniny/dopaminy do leczenia zaburzeń psychotycznych
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
KR20080080094A (ko) 2005-10-14 2008-09-02 하. 룬트벡 아크티에 셀스카브 에스시탈로프람 및 부프로피온의 저용량 조합물을 이용한중추신경계 장애의 치료 방법
US20070134322A1 (en) * 2005-12-14 2007-06-14 Forest Laboratories, Inc. Modified and pulsatile release pharmaceutical formulations of escitalopram
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1143702A (tr) 1965-03-18
GB1526331A (en) 1976-01-14 1978-09-27 Kefalas As Phthalanes
US4439545A (en) 1981-11-19 1984-03-27 Societe D "Expansion Scientifique "Expansia" Acrylic copolymers of N-acryloylpolymethyleneimines or N-acryloyldialkylamides, N,N'-acryloyldiaminoalcanes and N-acryloylaminoacids (or esters) their preparation and use as cation exchangers
GB8419963D0 (en) 1984-08-06 1984-09-12 Lundbeck & Co As H Intermediate compound and method
GB8607313D0 (en) * 1986-03-25 1986-04-30 Ici Plc Pharmaceutical compositions
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
US4902710A (en) 1988-12-14 1990-02-20 Eli Lilly And Company Serotonin and norepinephrine uptake inhibitors
US5114976A (en) 1989-01-06 1992-05-19 Norden Michael J Method for treating certain psychiatric disorders and certain psychiatric symptoms
US4962128A (en) 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
DK213290D0 (da) * 1990-09-06 1990-09-06 Lundbeck & Co As H Treatment of cerebrovascular disorders
US5296507A (en) * 1990-09-06 1994-03-22 H.Lundbeck A/S Treatment of cerbrovascular disorders
US5708035A (en) 1991-02-04 1998-01-13 Sepracor Inc. Methods of use and compositions of R(-) fluoxetine
AU1919592A (en) 1991-04-16 1992-11-17 National Institutes Of Health Method of treating trichotillomania and onychophagia
JPH07500812A (ja) 1991-11-15 1995-01-26 セプラコア，インコーポレーテッド 純粋なフルオキセチンのｓ（＋）異性体を用いる方法および組成物
EP0714663A3 (en) * 1994-11-28 1997-01-15 Lilly Co Eli Potentiation of drug responses by serotonin 1A receptor antagonists
US5627196A (en) * 1995-01-17 1997-05-06 Eli Lilly And Company Compounds having effects on serotonin-related systems
WO1996024353A1 (en) * 1995-02-10 1996-08-15 Eli Lilly And Company Methods of treating or preventing psychiatric disorders
US5554383A (en) 1995-04-06 1996-09-10 Trustees Of Tufts College Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
SE9501567D0 (sv) 1995-04-27 1995-04-27 Astra Ab A new combination
DK0759299T3 (da) 1995-08-16 2000-08-07 Lilly Co Eli Potensering af serotoninrespons
US5846982A (en) * 1996-06-14 1998-12-08 Eli Lilly And Company Inhibition of serotonin reuptake
US5912256A (en) * 1996-06-20 1999-06-15 Eli Lilly And Company Compounds having effects on serotonin-related systems
US5747494A (en) * 1996-06-28 1998-05-05 U C B S.A. Pharmaceutical compositions for the treatment of depressive disorders
US5958429A (en) 1996-08-16 1999-09-28 Eli Lilly And Company Potentiation of serotonin response
ZA977967B (en) 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders
US6069177A (en) 1997-07-08 2000-05-30 The Hong Kong University Of Science And Technology 3-Hydroxy-propanamine derived neuronal reuptake inhibitors
SE9703379D0 (sv) * 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703375D0 (sv) 1997-09-18 1997-09-18 Astra Ab A new combination
DE1042310T1 (de) * 1997-11-11 2001-04-19 Lundbeck & Co As H Verfahren zur herstellung von citaloprame
DK0957099T3 (da) * 1998-04-15 2003-03-17 Pfizer Prod Inc Heterocykliske carboxamider
JP2002519321A (ja) * 1998-06-30 2002-07-02 イーライ・リリー・アンド・カンパニー セロトニン関連系に効果を有するピロリジン、及び、ピロリン誘導体
AU771252B2 (en) 1998-07-13 2004-03-18 Nps Pharmaceuticals, Inc. Methods and compounds for treating depression and other disorders
WO2000003701A1 (en) 1998-07-16 2000-01-27 Massachusetts Institute Of Technology Composition for treatment of stress
US6579899B1 (en) 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
US6150376A (en) * 1998-08-05 2000-11-21 Georgetown University Bi- and tri-cyclic aza compounds and their uses
SE9803157D0 (sv) 1998-09-16 1998-09-16 Astra Ab A new composition
SE9803158D0 (sv) * 1998-09-16 1998-09-16 Astra Ab A new composition
PL199423B1 (pl) * 1998-10-20 2008-09-30 Lundbeck & Co As H Sposób wytwarzania citalopramu
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
DE69907037T3 (de) * 1999-04-14 2010-02-18 H. Lundbeck A/S Verfahren zur herstellung von citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6333357B1 (en) 1999-11-05 2001-12-25 Be Able, Llc Behavior chemotherapy
UA77650C2 (en) 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
WO2001080845A2 (en) 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
JP2002361405A (ja) * 2000-09-25 2002-12-18 Showa Denko Kk 熱交換器の製造方法
HUP0400054A3 (en) * 2001-05-01 2007-03-28 Lundbeck & Co As H The use of enantiomeric pure escitalopram

Also Published As

Publication number Publication date
HK1048069B (zh) 2005-12-16
ZA200108856B (en) 2002-12-24
AU5806100A (en) 2001-01-30
CO5190674A1 (es) 2002-08-29
BG110467A (en) 2010-01-29
EP1440691A3 (en) 2004-08-25
AU2005202686B2 (en) 2009-01-15
AR021155A1 (es) 2002-06-12
TR200402275T2 (tr) 2005-03-21
US20050101665A1 (en) 2005-05-12
CN1360501A (zh) 2002-07-24
IL146131A0 (en) 2002-07-25
JP4773011B2 (ja) 2011-09-14
DE60030861D1 (de) 2006-11-02
CZ200270A3 (cs) 2002-04-17
TR200402276T2 (tr) 2005-01-24
MY143278A (en) 2011-04-15
US7271194B2 (en) 2007-09-18
CA2373757A1 (en) 2001-01-18
US7265151B2 (en) 2007-09-04
UA77645C2 (en) 2007-01-15
HK1048069A1 (en) 2003-03-21
AU2008264188A1 (en) 2009-05-07
CL2008003941A1 (es) 2009-05-22
ATE339955T1 (de) 2006-10-15
MXPA01011626A (es) 2002-06-04
BR0011578A (pt) 2002-03-26
US6960613B2 (en) 2005-11-01
SK82002A3 (en) 2002-07-02
CL2008003939A1 (es) 2009-06-05
DK1200081T3 (da) 2006-12-27
IL170193A (en) 2010-04-29
CN1198610C (zh) 2005-04-27
WO2001003694A1 (en) 2001-01-18
EP1440689A2 (en) 2004-07-28
CA2373757C (en) 2010-01-05
CL2008003938A1 (es) 2009-05-22
IS6137A (is) 2001-10-30
DE60030861T2 (de) 2007-05-03
US20020086899A1 (en) 2002-07-04
AU2005202685B2 (en) 2009-01-15
US20070276035A1 (en) 2007-11-29
HRP20010820A2 (en) 2003-08-31
BG106279A (bg) 2002-08-30
IL170192A (en) 2010-04-29
EP1200081B1 (en) 2006-09-20
AU2005202685A1 (en) 2005-07-14
YU78701A (sh) 2004-03-12
IL146131A (en) 2007-02-11
IL170194A (en) 2010-05-31
PT1200081E (pt) 2007-01-31
NO20020062D0 (no) 2002-01-07
NO20020062L (no) 2002-01-07
SI1200081T1 (sl) 2007-02-28
US20040029957A1 (en) 2004-02-12
HUP0201791A3 (en) 2005-02-28
KR100604176B1 (ko) 2006-07-25
MEP2508A (xx) 2010-02-10
AU2008264182A1 (en) 2009-01-29
EP1200081A1 (en) 2002-05-02
NO329021B1 (no) 2010-07-26
AU2005202684A1 (en) 2005-07-14
EP1440691A2 (en) 2004-07-28
PL352030A1 (en) 2003-07-28
HUP0201791A2 (en) 2002-10-28
TWI232101B (en) 2005-05-11
BG110466A (en) 2010-01-29
EA200200137A1 (ru) 2002-06-27
AU782514B2 (en) 2005-08-04
CY1105806T1 (el) 2011-02-02
NO20100333L (no) 2002-01-07
US20040029958A1 (en) 2004-02-12
CA2687394A1 (en) 2001-01-18
KR20020015346A (ko) 2002-02-27
EP1440690A3 (en) 2004-08-18
ME00032B (me) 2010-02-10
EP1440689A3 (en) 2004-08-25
NO20100335L (no) 2002-01-07
JP2003504332A (ja) 2003-02-04
TR200402277T2 (tr) 2005-01-24
AU2005202684B2 (en) 2009-01-15
EP1440690A2 (en) 2004-07-28
US20040029956A1 (en) 2004-02-12
AU2005202686A1 (en) 2005-07-14
CA2687396A1 (en) 2001-01-18
BG110468A (en) 2010-01-29
NO20100334L (no) 2002-01-07
CA2687392A1 (en) 2001-01-18
ES2272298T3 (es) 2007-05-01
EA006555B1 (ru) 2006-02-24

Similar Documents

Publication Publication Date Title
TR200200014T2 (tr) Nörotik düzensizliklerin tedavisi.
WO2002053140A3 (en) New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
CY1106733T1 (el) Αγωγη νευρολογικης δυσλειτουργιας περιλαμβανουσα σουλφαμικες φρουκτοπυρανοζες και ερυθροποιητινη
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
EE200300212A (et) Ravimite kombinatsioonid (näiteks kloorpromasiin ja pentamidiin) neoplastiliste haiguste raviks
PL414996A1 (pl) Zastosowanie 40-O-(2-hydroksyetylo)-rapamycyny do wytwarzania leku do leczenia litych guzów ośrodkowego układu nerwowego
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
BR0206568A (pt) Novo método e composições para o tratamento local de doença de meniere, de zumbido no ouvido e/ou de perda de audição
NO20063308L (no) Kombinasjon av flupirtin og tramadol
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
BR0210650A (pt) Tablete, e, uso do mesmo
PT966285E (pt) Utilizacao de (+)mefloquina para o tratamento da malaria
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
MY136367A (en) Treatment of cognitive failure
BR0015938A (pt) Uso de antagonistas beta-adrenoceptores para a fabricação de um medicamento para o tratamento de desordens da retina externa
BR0115881A (pt) Emprego de compostos ciclohexanona substituìdos de 6-dimetilaminometil-1-fenil para a terapia da incontinência urinária
EA200001162A1 (ru) Новые лекарственные комбинации ингибиторов повторного поглощения норадреналина (иппна), предпочтительно ребоксетина и пиндолола
TR200002970T2 (tr) Sinir bozukluklarının yeni tedavileri
BR9807271A (pt) Tamoxifeno como terapia para reduzir diarréia induzida por cloridrato de irinotecano
DE60215219D1 (de) Verwendung von darifenacin zur behandlung des harndrangs
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2005020976A3 (en) Treatment of pervasive developmental disorders with norepinephrine reuptake inhibitors
AU2002234644A1 (en) Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases